Navigation Links
The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
Date:9/5/2007

cent (p=0,014) and for the ADONIS trial, 61.1 percent versus 72.8 percent (p=0,002).

"We are very pleased that these two large studies were positive and consistent in showing that dronedarone significantly reduced the recurrence of atrial fibrillation and flutter compared to placebo," says Bramah Singh, M.D., VA Medical Center West LA, David Geffen School of Medicine, University of California Los Angeles, and lead investigator of the trials.

In both studies, dronedarone also significantly reduced the ventricular rate during arrhythmia recurrence, a secondary endpoint. This therapeutic effect is also referred to as rate control, which consists of reducing the heart rate.

"Rate control is a very interesting feature of dronedarone and compliments the anti-arrhythmic effects of the drug," says Dr. Singh. "Rate control has been established to reduce symptoms."

A post-hoc analysis also showed that in the combined studies, dronedarone significantly reduced the rate of the combined end point of hospitalization or death compared to placebo. This important finding is being prospectively explored in an ongoing morbidity and mortality trial.

In the dronedarone arm of the studies, no episodes of "torsades de pointes," a serious ventricular arrhythmia observed with some existing treatments, were reported at one year and the incidence of adverse events (pulmonary toxicity, thyroid and liver dysfunction) was not significantly increased. In both studies, hyperthyroidism occurred less frequently in the dronedarone group versus placebo (8.4% vs 14.1%, P=0.0024) and elevated serum creatinine concentrations, which in some cases were reversible, occurred more frequently in the dronedarone group versus placebo (2.4% vs 0.2%, P=0.0039) without impact on renal function. Most common adverse events occurring in more than two percent of dronedarone treated patients, not statistically different from placebo, included cough, dyspnoea, hypothyroidism, bradycardia/con
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Arsenic May Have Been Responsible For The Madness Of King George III Of England
2. Indian Surgeon Conducts 70 Surgeries During His Holidays In England
3. Illegal Drug Use In England Mounting Up At An Alarming Rate
4. What Will Primary Care Look Like In England by 2015?
5. Ayurvedic Massage & English Food May Cheer England Team
6. Suicide Rates Drop To Lowest Ever In England
7. Head Of The Church Of England Asks NHS To Respect Patient Needs
8. More Accidents on England’s Road - Statistics Revea
9. England in the Grip of Dangerous Alcohol Addiction
10. Increase of Cancer drug usage in England
11. Cancer Drug Banned in England
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... (PRWEB) May 22, 2015 A new ... featuring experts in the field of Physical Therapy. ... that takes the mystery out of physical therapy and ... range of motion for a variety of ailments and ... establish a personalized exercise plan that enhances daily activities ...
(Date:5/22/2015)... May 22, 2015 Yisrayl Hawkins, Pastor and ... released a new letter calling on religious leaders to make ... which was published on his blog, discusses the history of ... needed to stop it. Yisrayl says mankind was created to ... experienced in today’s society. , “Yahweh created mankind, according ...
(Date:5/21/2015)... World Patent Marketing, a vertically integrated ... Motor Guide, a boat patent that aims to give ... boating industry has reached an annual revenue of $36.7 ... of World Patent Marketing , "Americans are taking ... steady growth of seven percent in new sales through ...
(Date:5/21/2015)... The Johns Hopkins Alliance for Science and Technology ... Board has selected a research project at the Veterans ... two $50,000 Abell Foundation Award for Excellence in Innovation ... Developed by the VA Maryland Exercise and Robotics ... Maryland School of Medicine and Massachusetts Institute of Technology ...
(Date:5/21/2015)... Irvine, CA (PRWEB) May 21, 2015 Bird ... industrial and residential applications recently added new sizes of the ... solutions. The affordable stainless steel bird spike is ... from landing or roosting on roof lines, parapet walls, I-beams, ... 10, 24, 50 and 100 foot boxes, allowing customers to ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 2Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 3
... of blood vessels in the eyes may offer insight into stroke ... react to high blood pressure, a major risk factor for stroke ... known as Atacand, improves blood flow in the eye, which can ... the lining of the vessel walls and plays a key role ...
... COPD is a term to describe conditions such as ... of airflow // and gradual loss of lung function ... leading cause of death in the United States. ... diagnose patients with chronic obstructive pulmonary disease earlier.Researchers compared ...
... growing waistline is bad for your health, but now a ... for your health.// ,When a company downsizes, it ... workers are concerned about their job and their future. But ... also have health problems. Workplaces that expanded their number of ...
... cells located at the base of the hair follicle. ... phases. In many people with hair loss, however, // ... number of abnormal follicles entering longer resting phases and ... the University of Pennsylvania School of Medicine have isolated ...
... has been done on patients for 10 years. The ... the more conventional large incision. While the patient clearly ... long-term benefits have not previously been studied. ,Laparoscopic ... choice after results from a new study. The study ...
... the initial mammogram immediately so any follow-up tests can ... 5 percent and 11 percent of all screening mammograms ... a follow-up mammogram. Many abnormal mammograms turn out to ... breast cancer diagnosis within one year. Even when follow-ups ...
Cached Medicine News:
(Date:5/21/2015)... 21, 2015 Townsend Design announced the ... Reliever, a soft shell single-upright osteoarthritis (OA) knee brace. ... relieve pain by reducing load on the side of ... Sales of the product in other countries will begin ... sewn-in integrated semi rigid frame and quick release buckles ...
(Date:5/21/2015)... Md. , May 21, 2015 ... open innovation competition designed to bring promising medical ... Heritage Provider Network (HPN) in collaboration with the ... for Advancing Innovation (CAI).  The winning teams were ... and live pitches and will move forward to ...
(Date:5/21/2015)... BOSTON , May 21, 2015  Juniper ... specialty pharmaceutical company focused on developing therapeutics that ... announced that CEO Frank Condella will ... as follows:Date: , Thursday, June 4, 2015Time: , ... & archive): , www.juniperpharma.com, under  ,Investor, ...
Breaking Medicine Technology:Townsend Announces Launch Of New Osteoarthritis Knee Brace 2Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 2Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 3Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 4Juniper Pharmaceuticals to Present at Jefferies 2015 Global Healthcare Conference on June 4, 2015 2
... ULURU Inc. (NYSE AMEX: ... development of a portfolio of wound management and oral ... for investment commitments with Ironridge Global BioPharma and its ... transactions, subject to certain conditions, to purchase common and ...
... Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), ... Data Safety Monitoring Board (DSMB) recently completed a ... Soligenix,s confirmatory Phase 3 clinical trial of orBec® ... acute gastrointestinal Graft-versus-Host disease (GI GVHD). ...
Cached Medicine Technology:ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price 2ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price 3Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 2Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 3Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 4Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 5Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: